Načítá se...

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

Lenalidomide is an orally active immunomodulatory drug that has direct antineoplastic activity and indirect effects mediated through multiple types of immune cells found in the tumor microenvironment, including B, T, natural killer (NK), and dendritic cells. Recently, the E3 ubiquitin ligase cereblo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Gribben, John G., Fowler, Nathan, Morschhauser, Franck
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5320950/
https://ncbi.nlm.nih.gov/pubmed/26195701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.5363
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!